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Renal selectivity properties towards endogenous albumin in minimal
change nephropathy. It is well accepted that the molecular charge and
conformation of serum proteins are major determinants of their glomer-
ular filtration, but few studies characterizing the molecular features of
circulating proteins in renal diseases are currently available. In 11
children affected by minimal change nephropathy (MCN) we deter-
mined the electrical charge and the fluorescence quantum yield of
Tyrosine (Tyr) and Tryptophan (Trp) (taken as index of conformation)
of serum and urinary albumin before and after steroid—induced remis-
sion of proteinuria. In all proteinuric children at the onset of the
disease, urinary albumin was formed by one band with an isoelectric
point (p1) of 4.7 (p1 of the native protein), and by numerous other, less
anionic bands with pis between 4.8 and 5.5 accounting for about 50% of
the total amount of this protein. The normalization of proteinuria which
followed steroid therapy was characterized by the disappearance in
urines of the less anionic fraction and by the appearance of numerous
isoforms with apI still more anionic (p1 <4.7) than normal. At the same
time, in the proteinuric phase, the fluorescence quantum yield of Trp of
urinary albumin was markedly quenched, returning to near normal
levels after steroid—induced remission of proteinuria. These data indi-
cate that in MCN the charge—dependent renal selectivity properties are
partially maintained and that the less anionic isoforms of albumin are a
main component of urinary albumin. Together with the electrical
charge, the conformation of albumin as a major determinant of its
urinary excretion in MCN must also be considered.
In the last decade many studies have described the selective
properties of the glomerular basement membrane (GBM)
towards macromolecules [1—31 and have applied the emerging
concepts to explain proteinuria in minimal change nephropathy
(MCN) [4, 5]. Normal GBM is currently viewed as a porous
filter which allows the passage of molecules on the basis of their
size, electrical charge and conformation [1—3]; the body of
evidence obtained from studies on human MCN points to an
electrostatic defect in the GBM as a main determinant of
proteinuria [4, 5]. Accordingly, in MCN the loss of anionic
charges by GBM would be the major cause of the urinary
excretion of albumin, which in normal conditions is retained in
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the vascular bed owing to an electrostatic interaction with the
negatively charged structures of GBM.
Recent data on the electrical charge of albumin in normal
conditions have demonstrated that at least in urine, albumin is
not a homogeneous protein but a microheterogeneous one with
a wide range of electrical charge still more anionic than the
serum homologue [6].
The direct evaluation of the electrical charge of albumin in
MCN (so far unreported) seems of paramount importance in
that it would directly describe the changes, if any, in GBM
selectivity properties towards the electrical charge of circulat-
ing albumin and therefore lay the basis for the understanding of
the mechanisms underlying albuminuria in this disease. The
characterization of the electrical charge and the conformational
adaptation of serum and urinary albumin in children with MCN
are the topics of the present study.
Methods
Patients
Eleven children with a mean age of 8.4 years (range 2.4 to
15.1) affected by nephrotic syndrome and responsive to steroid
therapy, were considered in this study (Table 1). By current
criteria, the underlying renal disease was classified as MCN in
all cases. Children considered in this study had high selective
proteinuria [immunoglobulin G (IgG) clearance/transferrin (Tr)
clearance <0.1]. Common laboratory parameters (C3, C4,
CH5O, ANA, Ra test, HBsAg) were unexpressive in all cases; a
renal bioptic fragment obtained in four cases revealed no renal
lesions at light microscopy nor were there immunodeposits at
immunofluorescence (excluding scattered C3).
The steroid regimen was in accordance with the protocol of
the ISKDC [7] (prednisone: 60 mglm2/day for four weeks
followed by 40 mg/m2/day given on 3 consecutive days out of 7
for 4 weeks). Serum samples were obtained in the morning after
an overnight fast, at the discovery of proteinuria when the
steroid regimen had not yet started and after three days of
steroid—induced normalization of proteinuria. Twenty—four
hour urine collections were obtained at the same times.
Patient 4 enjoyed remission without steroid therapy; for
patient 3, owing to acute appendicitis, the second urine collec-
tion was performed one month after normalization of protein-
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Table 1. Renal function, protem excretion in subjects with minimal change nephrotic syndrome
Patient
Age
years
S Cr
mg%
Tot S Pr
g%
Tot U Pr
g/m/m2
Select
Index IgG
CIITr CI
U Aib
g/m/m2
1
2
3
4
5
6
7
8
9
10
11
mean SEM
13
10
8.16
13.58
9.58
15.08
7
4.66
3.67
2.42
5.58
pre-t 0.7
post-t 0.7
pre-t 0.6
post-t 0.5
pre-t 0.6
post-t 0.5
pre-t 0.5
post-t 0.6
pre-t 0.4
post-t 0.5
pre-t 0.8
post-t 0.8
pre-t 0.4
post-t 0.4
pre-t 0.4
post-t 0.4
pre-t 0.5
post-t 0.4
pre-t 0.4
post-t 0.5
pre-t 0.5
post-t 0.6
pre-t 0.53 0.04
post-t 0.54 0.04
3.3
5.0
3.7
5.2
4.5
7.0
5.3
6.0
3.9
5.3
5.3
6.3
4.4
5.0
4.5
5.8
4.3
5.7
5.2
5.9
5.0
6.1
4.49 0.20
5.76 0.18
1417
37
5361
64
2625
206
7600
32
5870
272
8160
82
3636
95
1818
29
1167
45
1833
46
3544
48
3911.9 750.2
86.9 23.9
0.07
0.02
0.06
0.061
0.088
0.053
0.056
0.06
0.059
0.047
0.061
0.06 0.01
417
6
69
6
1233
13
4560
3
246
7
4100
9
1331
8
512
8
457
8
643
8
863
8
1311.9 465.5
7.6 0.8
Abbreviations are: S Cr, serum creatinine; Tot S Pr, total serum protein; Tot U Pr, total urinary protein; Select Index, selectivity index; U Alb,
urinary albumin; IgG, immunoglobulin 0; Tr, transferrin; pre-t, before therapy; post-t, after therapy.
uria when he was undergoing intermittent steroid therapy. Only
these two patients had a recurrence of proteinuria eight days
and one month after remission, respectively.
Ten normal children of the same mean age (11.2 yrs; range 4
to 15) were used as normal controls for fluorimetric spectra; the
IEF study was performed in six subjects out of this control
group. Six adult patients (mean 30 yrs; range 21.5 to 42) affected
by nephrotic syndrome due to immunologically mediated le-
sions (on the basis of bioptic data 3 membranous and 3
membranoproliferative glomerulonephritis), who were hypoal-
buminemic to the same extent as MCN children were also
studied.
Purification of albumin
Albumin was purified from other serum and urinary proteins
by employing pseudo-ligand chromatography on Affi-Gel Blue
with a modification [8] of the original method of Travis [9]. In a
resin—packed 1.5 x 7 cm column equilibrated with 0.05 M
Tris-HC1, 0.25 M KCI pH 7, 1 ml of serum diluted in 400 ml of
0.01 M Tris-HC1, 0.35 M, NaCI pH 7 and different amounts of
urine diluted to the same protein content as 1 ml of serum and
to the same molarity as the buffer (0.35) were applied. The
separation was carried out at room temperature, with a flow
rate of 50 mllhr using sufficient equilibrating buffer to reach 0
optical density of the effluent. The same equilibrating buffer
enriched with 1.5 M KC1 was used to desorb albumin. All
albumin samples were immediately ultrafiltered (Amicon PM,
30 membranes) and dialyzed against water. Regeneration of
Affi-Gel Blue was achieved by washing the resin alternately
with 10 column volumes of 0.1 M Tris-HCI, 0.5 M NaCl pH 8
and 0.1 M acetate buffer 0.5 M NaCl pH 4.5. Albumin was
analyzed in all cases by immunoelectrophoresis according to
Grabar and Williams [101 in a 1% agarose gel. Recoveries of
albumin from both serums and urines were greater than 95% in
all cases.
Isoelectric focusing (IEF), silver stain
Ultrathin (240 pm) IEF was performed in polyacrylamide
slab gels (T = 5%, C = 3%) cast on silanized glass plates (13 X
13 cm) [11]. Gaskets were formed with paraflim rectangles, one
layer giving approximately 120 pm thickness. The polymeriza-
tion solution contained 12% glycerol and an appropriate amount
of ammonium persulfate as a catalyst, TEMED as an acceler-
ator and 2.5% (vol/vol) carrier ampholytes (LKB, Bromma,
Sweden) in two non-linear ranges of pH between 4 and 6 for
urine and between 4 and 7 for serum. The pH gradient was
evaluated with six p1 marker proteins (Pharmacia, Uppsala,
Sweden) and with an LKB surface electrode. The runs were
performed at 10°C by applying 2000 volts, 13 watts, for six
hours; prefocusing was for one hour at 500 volts, 13 watts.
Electrode solutions were 0.2 M NaOH at the cathode and 0.2 M
H3P04—0. 1 M glutamic acid at the anode. Albumin in constant
aliquots of 50 jg was applied with paper strips.
Silver staining was performed with the photochemical
method of Merril, Goldman and Vonkeuren [12]. After TCA
fixation, the gels were rinsed three times for 10 minutes each in
10% ethanol—5% acetic acid and subsequently treated for 10
minutes with 3.4 mM K2Cr2O7/3.2 mi HNO3 in the dark with
gentle agitation. The gels were then placed in a 10 mts AgNO3
solution under a high—intensity uniform light for 30 minutes.
The developer was prepared by mixing 0.28 M NaHCO3 and 0.5
ml of 40% formaldehyde; the reaction was stopped with acetic
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Table 2. Fluorescence emission intensity ( ) at 303 (Tyr) and 330 (Trp) of albumin when excited at 275 nm; Results are given as mean SEM
Patients N
Serum albumin Urinary albumin
303nm 330nm 303/330303nm 330nm I 303/330
Normals 10 36 2 36 2 1.0 43.3 0.8 54.4 1.5 0.80 0.04
MCN 11 pre-t
post-t
38.5 4.2
36.1 2.8
41.6 3.9
39.2 3.1
0.93
0.93
0.03
0.02
37.6
39.8
2.5
4.1
37.9 3.2°
46.3 5.3
1.01 001b
0.87 0.03
a P < 0.001 compared to normals
b P < 0.001 compared to MCN group after therapy
acid. All steps were carried out at room temperature with
freshly made reagents.
Immunofixation
Immunofixation of IEF gels of albumin was achieved by
covering the dried gel, after electrophoresis, with cellulose
acetate strips (25 x 11 cm, Sepraphore III, Gelman C.O., Ann
Arbor, Michigan, USA) soaked in dilutions of anti-albumin
antibodies (Dako, Copenhagen, DK). After incubation for 60
minutes at room temperature in a moist box, the strips were
removed and the gels washed for 24 hours in a 0.9% NaC1
solution, which was changed four times, and with H20 for 30
minutes [13].
Bidimensional immunoelectrophoresis
Bidimensional immunoelectrophoresis directly from IEF gels
was performed according to Kessler [14] in a 1% agarose gel
containing anti-albumin antibodies (400 d) as the first layer and
anti-total serum protein antibodies (800 tl) as the second layer.
Fluorimetric spectra
Fluorimetric spectra were recorded with a Perkin Elmer
MPF-44 A spectrofluorimeter (Perkin Elmer, Norwalk, Con-
necticut, USA) in standard, 10 mm optical path, quartz cuvettes
at a constant 33°C. Quinine sulfate was used for calibration of
the spectrofluorimeter. The intrinsic fluorescence intensity (I)
of Tyr and Trp upon excitation at 275 nm was measured as
height in mm per mg of protein of the peak at 303 and 330 nm,
respectively. Spectra at 330 were corrected for contribution of
Tyr at this wavelength (I Tyr 330), calculated from I at 290 nm
and 330 nm of a known Tyr standard, compared with the sample
to be calculated following the formula I Tyr 330 = I 330
standard Tyr X I 290 sample/I 290 standard Tyr. Corrected I 330
was then obtained by subtracting I Tyr 330 from I 330 of the
sample.
Other methods
Coomassie G250 binding assay [15] as modified by Read and
Northcate [16] was used to evaluate total proteinuria. Urinary
albumin and IgG were determined by means of nephelometry
(Beckman Immunoanalyzer, Fullerton, California, USA). The
glomerular selectivity index was calculated as the ratio between
IgG clearance and Tr clearance, determined by radial immuno-
diffusion.
Statistical methods
One—way analysis of variance and t-paired tests were used for
the calculation of significance in Table 2. Results are given as
mean SEM.
Results
Albumin was the only urinary protein detectable by im-
munonephelometry. Nevertheless total proteinuria estimated
with Coomassie G250 exceeded by a mean factor of 3 the
amount of urinary albumin determined by nephelomethry. This
discrepancy could possibly be explained by the difference in
analytical methods used; the affinity of the Coomassie dye is
indeed very different for any given protein, therefore the use of
a single standard (HSA in this case) may lead to over— or
underestimation of an assortment of proteins. Alternatively, the
presence in urines of other proteins that are not currently
determined as clinical parameters may to some extent deter-
mine this difference.
In all patients the steroid regimen resulted in normalization of
the urinary excretion of proteins within 14.8 1.9 days. Total
proteinuria fell from 4087 1104 g/min to 80 22 p.g/min and
albuminuria from 1668 781 sg/min to 6.6 0.7 g/min.
All patients were followed for a period of four months and all
were normoproteinuric excluding patients 3 and 4 (in whom
proteinuria recurred after 30 and 8 days, respectively).
IEF of serum and urinary albumin
The patterns at IEF of serum albumin purified with pseudo-
ligand chromatography from the foregoing patients at the onset
(tracks a, c, e, g, i, m, o, q, s, u) and after remission (tracks b,
d, f, h, 1, n, p, r, t, v) of proteinuria are shown in Figure 1. The
main serum component was in all cases a cluster of bands
centered around p1 4.7. The p1 gradient chosen in this case for
evaluating a large p1 range between 4.0 and 7.0 did not allow a
precise determination of the two limits of the main component;
it is, however, clear that it does not exceed apI of 4.8 to 4.9. In
five patients (1, 2, 5, 9, 10) the serum pattern at the onset of
proteinuria was characterized by the presence, in addition to
the main band, of a few subtle isoforms with a p1 around 5.8
(indicated by an arrow in Fig. 1A and B). As shown by
bidimensional electrophoresis in a two—layer gel (Fig. 2), all
these isoforms remained in the first layer containing anti-human
albumin antibodies while no contaminant was detectable in the
second layer containing antibodies against whole serum pro-
teins. By contrast, in no case did normal children and compa-
rably—hypoalbumiemic nephrotic adults show the presence of
less anionic albumin (Fig. 3).
Figure 4 show the pattern of urinary albumin of 11 MCN
patients before (tracks a, c, e, g, i, m, o, q, s, u, z) and after (b,
d, f, h, 1, n, p, r, t, v, x) the steroid—induced remission of
proteinuria. By taking as reference the main unmodified cluster
at p1 4.7, urinary albumin during the normoproteinuric phase is
characterized by the presence, besides the main band with p1
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4.7, of numerous other isoforms with pls still more anionic
(between 4.0 and 4.6).
On the other hand, in the proteinuric phase some marked
differences can be noticed; here, urinary albumin is formed by
the main unmodified band at p1 4.7 representing about 50% of
the whole material, and by many others with a more cationic p1
focusing between 4.8 and 5.5. Finally a subtle band is visible in
the upper part of the gel with a p1 around 5.8. Tracks a, c, i, m,
q, s, and u are the most representative of this trend. All the less
anionic isoforms were immunofixed on the gel surface by
treatment with polyclonal anti-human albumin—antibodies (Fig.
4C), while the non-immunotreated samples were rapidly lost
from the gel during the extensive washings with NaC1 solutions.
Furthermore, all these bands were characterized as albumin by
bidimensional immunoelectrophoresis (Fig. 5).
Two exceptions to the general trend in the normoproteinunc
phase (namely highly anionic isoforms) are represented by
patients 3 and 4 (Fig. 4A, tracks f and h). In these cases the
albumin subunits with pls between 4.8 and 5.5 were also
detectable after remission of proteinuria, whereas there were no
isoforms with a p1 lower than 4.7. Compared to the others, in
Fig. 1. Isoelectric focusing pattern of serum
albumin in children affected by MCN. The
pattern of serum albumin before and after
therapy is presented in succession. A. Tracks
a, c, e, g, i, m, o, q, s, u show the pattern
before steroid therapy. B. Tracks b, d, f, h, 1,
n, p, r, t, v show the pattern after treatment.
Arrows indicate less anionic isoalbumins.
both patients (patients 3, 4) the time course of proteinuna was
atypical, in that nephrotic syndrome recurred after 30 and 8
days, respectively. Finally (Fig. 6) urine of non-MCN patients
failed to show less anionic albumins, suggesting that the pattern
described is characteristic of MCN children.
Fluorimetric spectra
The I 303 and I 330 of serum albumin in patients with MCN
were the same as in normal subjects during both the proteinuric
and the non-proteinuric phases, with only slight modification of
the I 303/330 (Table 2). In contrast, urinary albumin showed a
slight decrease in I 303 compared to normal controls both in the
proteinuric and in the non-proteinuric phases, and a significant
decrease in I 330 which is statistically significant for the
proteinuric group. As a consequence I 303/330 is significantly
higher in the proteinuric phase compared to both the non-
proteinuric phase and normal subjects.
Discussion
The size of solutes and macromolecules is the first determi-
nant of their renal selectivity, a mechanism whereby small
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1FF p' LI
ANTI ALB.
AS
Li
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Fig. 2. Bidimensional electrophoresis of sample 'a" from IEF. First
dimension was IEF, the second dimension was immunoelectrophoresis
against a two layer gel [17].
molecules and proteins of small molecular radius are freely
excreted while larger proteins are retained in the vascular bed
[1]. It is, however, well known that a model for protein filtration
based on size alone cannot by itself explain the behaviour of
certain plasma proteins, such as albumin, which are filtered in
considerably smaller amount compared to neutral compounds
of the same molecular radius [2, 31. This is due to the electro-
static interaction of albumin with the negatively charged
sialoproteins localized on the surface of endothelial and epithe-
hal cells of the GBM. Studies of the electrostatic nature of the
GBM have unequivocally demonstrated that for any given
macromolecule a higher urinary excretion corresponds to a
more cationic p1 [17—191.
Finally, in addition to size and charge, also shape and
deformability have been recognized as determinants of the
passage of macromolecules through the GBM [20, 21].
Taken together, these notions constitute the basis for the
definition of pathophysiology of proteinuria in MCN, a disease
characterized by high levels of proteinuria (mainly albuminuria)
and by the absence of detectable histological alterations of the
kidney. Evidence that proteinuria in human MCN derives from
a defective electrostatic interaction between glomerular
polyanions and circulating albumin comes from the data of
Carrie, Salyer and Myers who found a diminished uptake of
colloidal iron in glomeruli of patients with MCN [4].
Our data characterize the charge—mediated renal properties
of selectivity towards endogenous albumin in the normal and
proteinuric phases of human MCN employing a very sensitive
technique such as IEF in ultrathin layers (240 m) and narrow
pH gradients (pH 4.0 to 6.5) associated to silver stain of the
protein.
By analogy with normal adults [6] the composition of urinary
albumin in the normoproteinuric phase of MCN includes a main
band with p1 4.7 and numerous other isoforms with a p1 still
more anionic. More anionic urinary albumins have previously
been characterized as glycosyl albumin [6].
The presence of serum isoalbumins with a less anionic p1 and
their relatively higher concentration (compared to the unmodi-
fied protein) in urines during the proteinuric phase of MCN
clearly indicate that notwithstanding the reported variation of
glomerular polyanions [4], the electrical function of GBM
(namely filtration of proteins on the basis of their electrical
charge) is partially maintained [21].
By this token, in MCN, an abundant portion of normally
charged albumin is retained in the vascular bed, presumably
owing to the interaction with the still present polyanions of
GBM. Furthermore, in analogy with other authors who em-
ployed large pH gradient IEF [22] we found that urinary
albumin in other nephropathies is homogeneous containing only
the more anionic isoforms (that in our experiment have a p1 of
4.7).
These findings point to a main role of anomalously charged
albumin in albuminuria in MCN, which represents the remain-
ing quota of urinary albumin. Although on a theoretical ground
the two phenomena could be linked together (namely polyanion
saturation produced by binding of anomalous albumin), no
further conclusion can be reasonably drawn on the basis of
present observations. Most of the data currently available on
the effects of the saturation of GBM polyanions on proteinuria
have been obtained in rats by infusing strong polycations such
as hexadimetrine [23] and protamine sulfate [24]. This animal
model is different indeed when compared to the clinical model
of MCN proteinuria, where only moderately cationic protein is
described. The present evidence could therefore stimulate a
new line of research on the effects of only partially—cationic
proteins on GBM function, especially since the aforementioned
proteins could be purified from human serum by the techniques
here described.
A point which deserves further attention is the possibility that
a failure of the tubular reabsorption of the less anionic isoalbu-
mins could be the main reason for their urinary enrichment in
the proteinuric phase of MCN. Indeed, the renal handling of
albumin is due to a balance between filtration through the GBM
and tubular reabsorption which is a charge—dependent process
[25]. Studies on tubular reabsorption of proteins in rats have
clearly indicated that cationic proteins are more easily reab-
sorbed than anionic ones [25]; therefore, the failure of this
process would produce a urinary enrichment of albumin iso-
forms with charge alteration. Some points, however, are in
contrast with this possibility: 1) tubular reabsorption of albumin
is a saturable process, and in animal models with immunologi-
cally—mediated nephrotic syndrome the urinary composition of
albumin almost completely represents the amount filtered [26];
2) assuming an average concentration of less anionic albumin of
50% and an average total albuminuria of 1 g/hiter, the quota of
reabsorbed albumin would exceed 500 mg/liter, too high an
amount indeed, which would overload the tubular capacity; 3) a
tubular defect per se would produce a nonselective passage into
urines of serum albumin, therefore no difference in electrical
charge would exist between serum and urinary albumin [26];
and 4) the relatively lower concentration in urines of unmodified
albumin (p1 4.7) compared to the less anionic isoforms would
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Fig. 3. A. Isoelectric focusing of serum albumin pur(fied from 6 normal children of the same mean age. Silver stain. B. Isoelectric focusing of
serum albumin purified from adult patients with a nephrotic syndrome other than minimal change. Silver stain.
mean a facilitated reabsorption of frankly anionic albumin in the
proteinuric phase of MCN, an assumption that is not supported
by current knowledge of tubular functions [25]. On these bases
it seems possible to exclude a main tubular effect as a determi-
nant of the pattern of urinary albumin in MCN; any such
influence would be supposed in the non-proteinuric phase,
during which albumin is mainly composed of more anionic
isospecies whose tubular uptake is less facilitated than that of
normally charged albumin.
The biochemical significance of such altered albumins is
currently unknown. Both an abnormally high binding of hitherto
uncharacterized cationic substances or an abnormally low binding
of anionic ones (fatty acids?) may be hypothesized. Further
studies are needed to improve our understanding of the topic.
In an attempt to develop part of these studies we have taken
into consideration the conformation of serum and urinary
albumin, since it seemed reasonable that the alteration of
albumin p1 could possibly result in a variation of the albumin
conformational adaptation.
Studies on renal handling of albumin in normal and patholog-
ical conditions have demonstrated that together with the elec-
trical charge, conformation is a main determinant of the renal
handling of the protein [1, 2]. In investigating albumin confor-
mation we have turned to the fluorimetric spectra of the protein,
taking particular account of the emission quantum yields at 303
nm and 330 nm upon excitation at 275 nm, since these are the
emission bands of two aromatic residues, Tyr and Trp, respec-
tively [27. 28]. At these wavelengths the intrinsic fluorescence
changes in intensity are able to probe a change in the environ-
ment of the two aromatic groups within the three—dimensional
structure of the protein [29, 30]. Human albumin is from this
point of view a unique case in that it contains only a single Trp
per 69,000 daltons, localized in the second domain of the
protein and precisely, according to Brown's model, in position
214 [31].
By current criteria, a variation in the fluorescence quantum
yield of Trp is synonymous with a conformational alteration of
albumin [30], involving a modification of the spatial configura-
tion near this domain. From the present data it appears that
while in normal conditions and in the non-proteinuric phase of
MCN, urinary albumin maintains a normal relationship between
the intensity emissions of Tyr (303 nm) and Trp (330 nm,
typically I Trp is 20% to 30% greater than I Tyr), in proteinuria
of MCN patients the intensity quantum yield of Trp is quenched
significantly, indicating a conformational alteration. This alter-
ation is more pronounced in urines than in serum, indicating a
priviledged passage of altered albumins into urines.
The most plausible, albeit speculative, explanation for this
finding is that the high urinary excretion of more cationic
albumin happens in concomitance with an alteration of confor-
mationally mediated permselectivity of the GBM.
Once again, however, a tubular effect could in part explain
the data on conformation of urinary albumin, and this seems
particulary true for the observations of the urinary composition
in the normoproteinuric phase. Nevertheless, by considering
the data on electrical charge and conformation of urinary
albumin in the proteinuric phase, it seems reasonable to con-
clude that the tubular effect is only of minor importance in such
a phenomenon during the proteinuric phase.
In conclusion, these hitherto unknown features of serum and
urinary albumin in MCN seem in our opinion to be relevant to
the renal handling of this protein in the proteinuric condition.
These data would constitute the basis for new biochemical
considerations about the structure of albumin in MCN.
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Fig. 4. Isoelectric focusing pattern of urinary
albumin in children affected by MCN. The
pattern of urinary albumin before and after
steroid induced remission of proteinuria is
presented in succession. A. Tracks a, c, e, g,
i, m, o, q, s, u, z show urinary albumin before
therapy while B. tracks b, d, f, h, I, n, p, r, t,
v, x show the pattern after treatment. The
tracks z and x refer to patient 11, whose
serum albumin has not been shown.
Photochemical silver stain. Arrows indicate
less anionic isoalbumins. C. Immunofixation
of samples a, b, c, with anti-human albumin
antibodies. Immunofixation was performed
following the technique of Confavreux [13]. In
position "d" and "e" the same samples were
electrofocused but not immunofixed with
anti-human albumin antibodies and therefore
the protein was lost during extensive washings
with saline solution.
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Fig. 5. Bidimensional immunoelectrophoresis of sample "a" from
IEF. First dimension was IEF, and the second dimension was im-
munoelectrophoresis against a two layer gel.
Fig. 6. Isoelectric focusing of urinary albumin purfied from 6 patients
with a nephrotic syndrome other than MCN (3 membranous, 3
membranoprolferative glomerulonephrites).
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